SOBI:STO
Swedish Orphan Biovitrum
452,00 SEK
arrow_downward
-1,40%(-6,40) 1D
22. okt., 17.29.32 GMT+2 · SEK
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for SOBI...
Åbn
448,00 SEK
Høj
454,40 SEK
Lav
444,40 SEK
Markedsværdi
161,65 mia.
Gns. vol.
259,17 t
Volumen
219,69 t
P/E-forhold
120,72
Højeste i 52 uger
487,00 SEK
Laveste i 52 uger
310,60 SEK
Indtægt pr. aktie
3,74 SEK
Aktier i omløb
357,64 mio.
Antal ansatte
2 t
Åbn
448,00 SEK
Høj
454,40 SEK
Lav
444,40 SEK
Markedsværdi
161,65 mia.
Gns. vol.
259,17 t
Volumen
219,69 t
P/E-forhold
120,72
Højeste i 52 uger
487,00 SEK
Laveste i 52 uger
310,60 SEK
Indtægt pr. aktie
3,74 SEK
Aktier i omløb
357,64 mio.
Antal ansatte
2 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Traders Union
·
for 6 timer siden
SPX falder, da svagt momentum tynger S&P 500-indekset
Yahoo Finance
·
for 1 time siden
The Stock Market Sounds an Alarm for the First Time in Nearly 27 Years. Here Is What History Says the S&P 500 Will Do Next.
FinancialContent
·
for 24 minutter siden
1st Source (NASDAQ:SRCE) posts better-than-expected sales in Q3 2026
The Motley Fool
·
for 20 minutter siden
The S&P 500 Is Just Shy of a Record With 10 Weeks Left in the Year. Here's What History Says Could Happen Next.
Profil
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
Om Swedish Orphan Biovitrum